Skip to content
10-Q

Quarterly Report

SPARK THERAPEUTICS, INC.

0001609351-19-000047

← back to feed
Filed
May 10, 2019 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2019 · May 2, 2019 38.41M sh
Capex Q1 2019 · Mar 31, 2019 $4.29M
Capex Q1 2019 · Mar 31, 2018 $4.14M
Operating Cash Flow Q1 2019 · Mar 31, 2019 −$32.1M
Operating Cash Flow Q1 2019 · Mar 31, 2018 $53M
Long Term Debt Q1 2019 · Mar 31, 2019 $44.51M
Long Term Debt Q1 2019 · Dec 31, 2018 $46.09M
Short Term Debt Q1 2019 · Mar 31, 2019 $6.33M
Short Term Debt Q1 2019 · Dec 31, 2018 $4.82M
Cash And Equivalents Q1 2019 · Mar 31, 2019 $76.32M
Cash And Equivalents Q1 2019 · Dec 31, 2018 $95.25M
Stockholders Equity Q1 2019 · Mar 31, 2019 $451.03M
Stockholders Equity Q1 2019 · Dec 31, 2018 $496.51M
Stockholders Equity restated Q1 2019 · Mar 31, 2018 $479.67M
Stockholders Equity Q1 2019 · Dec 31, 2017 $513.62M
Current Liabilities Q1 2019 · Mar 31, 2019 $86.44M
Current Liabilities Q1 2019 · Dec 31, 2018 $62.35M
Total Liabilities Q1 2019 · Mar 31, 2019 $304.48M
Total Liabilities Q1 2019 · Dec 31, 2018 $317.84M
Current Assets Q1 2019 · Mar 31, 2019 $513.44M
Current Assets Q1 2019 · Dec 31, 2018 $567.14M
Total Assets Q1 2019 · Mar 31, 2019 $755.51M
Total Assets Q1 2019 · Dec 31, 2018 $814.35M
Net Income Q1 2019 · Mar 31, 2019 −$54.36M
Net Income Q1 2019 · Mar 31, 2018 −$46.37M
Operating Income Q1 2019 · Mar 31, 2019 −$56.85M
Operating Income Q1 2019 · Mar 31, 2018 −$48.91M
Revenue Q1 2019 · Mar 31, 2019 $20.77M
Revenue Q1 2019 · Mar 31, 2018 $15.68M